title: Reciprocal regional changes in brain NPY receptor density during dietary restriction and dietary-induced obesity in the rat.
abstract: Neuropeptide Y (NPY) potently induces feeding, reduces thermogenesis and induces obesity in rats when injected into the cerebral ventricles. Groups of male Wistar rats were either restricted to 60% of their normal daily food intake over 10 days or made obese by presenting them with a high-calorie diet rich in sugars and fat over 6 weeks. Food restricted rats lost up to 20% of their body weight, compared with control rats and had large reductions in their body fat mass. By contrast, rats with dietary-induced obesity weighed 26% more than controls due mainly to increased body fat mass. Quantitative receptor autoradiography demonstrated reduced [(125)I]PYY binding in the hypothalamic lateral (perifornical) and dorsal areas, hypothalamic ventromedial, arcuate and dorsomedial nuclei, hippocampal CA3 region, centromedial amygdaloid nucleus and thalamic paraventricular and reuniens nuclei in dietary restricted rats compared with controls. By contrast, regional [(125)I]PYY binding was significantly increased in hypothalamic lateral and dorsal areas, hypothalamic arcuate and dorsomedial nuclei, amygdaloid medial and centromedial nuclei, thalamic centromedial and paraventricular nuclei of dietary obese rats versus controls. Masking NPY Y1 receptors with 1 microM BIBP3226, a selective Y1 receptor antagonist, revealed that the changes in [(125)I]PYY binding in brains of food-restricted and dietary-obese rats were due to changes in BIBP3226-insensitive binding sites, presumably Y2 or Y5 NPY receptors. These data suggest that dietary-restriction stimulates NPY release resulting in down-regulation of NPY Y5 'feeding' and/or Y2 receptors and reduced BAT thermogenesis thereby providing an increased drive to eat to restore normal caloric intake whilst reducing thermogenesis in order to conserve fat reserves. By contrast, the up-regulation of NPY Y5 and/or Y2 receptors in dietary-induced obesity is consistent with inhibition of NPY release in the hypothalamus, amygdala and thalamus. Overall, we suggest that there is a regional increase in NPY release during negative energy balance, such as during food-restriction and a reduced regional release of NPY in positive energy balance, such as during hyperphagia associated with the development of obesity.
authors.affiliation: Department of Medicine, University of Liverpool, UK.
authors.forename: P S
authors.initials: PS
authors.lastname: Widdowson
authors.forename: R
authors.initials: R
authors.lastname: Upton
authors.forename: L
authors.initials: L
authors.lastname: Henderson
authors.forename: R
authors.initials: R
authors.lastname: Buckingham
authors.forename: S
authors.initials: S
authors.lastname: Wilson
authors.forename: G
authors.initials: G
authors.lastname: Williams
mesh_terms: D000679:Amygdala / Q000378:metabolism; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D001345:Autoradiography; D001665:Binding Sites / Q000187:drug effects; D004032:Diet; D007031:Hypothalamus / Q000378:metabolism; D008297:Male; D009765:Obesity / Q000209:etiology* / Q000378:metabolism*; D019894:Peptide YY / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D017476:Receptors, Neuropeptide Y / Q000187:drug effects / Q000378:metabolism*; D013787:Thalamic Nuclei / Q000378:metabolism; D014018:Tissue Distribution
chemical_list: C092926:BIBP 3226; D017476:Receptors, Neuropeptide Y; D019894:Peptide YY; D001120:Arginine